Search Results - "Yamazaki, Mayako"

Refine Results
  1. 1

    Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats by Yamazaki, Mayako, Honda, Sokichi, Tamaki, Keisuke, Irie, Megumi, Mihara, Takuma

    Published in PloS one (24-07-2020)
    “…Auditory steady-state responses (ASSRs) are states in which the electrical activity of the brain reacts steadily to repeated auditory stimuli. They are known…”
    Get full text
    Journal Article
  2. 2

    Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors by Chino, Ayaka, Seo, Ryushi, Amano, Yasushi, Namatame, Ichiji, Hamaguchi, Wataru, Honbou, Kazuya, Mihara, Takuma, Yamazaki, Mayako, Tomishima, Masaki, Masuda, Naoyuki

    “…In this study, we report the identification of potent pyrimidoindazoles as phosphodiesterase10A (PDE10A) inhibitors by using the method of fragment-based drug…”
    Get full text
    Journal Article
  3. 3

    Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats by Yamazaki, Mayako, Okabe, Mayuko, Yamamoto, Noriyuki, Yarimizu, Junko, Harada, Katsuya

    Published in Journal of pharmacological sciences (01-03-2015)
    “…Despite the human 5-HT5A receptor being cloned in 1994, the biological function of this receptor has not been extensively characterized due to a lack of…”
    Get full text
    Journal Article
  4. 4

    5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1- Targeted Transgenic Male Rat Model of Fragile X Syndrome by Yamazaki, Mayako, Arai, Takatomo, Yarimizu, Junko, Matsumoto, Mitsuyuki

    “…Abstract Background Fragile X syndrome (FXS) is a genetic condition that causes a range of developmental problems, including intellectual disability,…”
    Get full text
    Journal Article
  5. 5

    5-H[T.sub.5A] Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome by Yamazaki, Mayako, Arai, Takatomo, Yarimizu, Junko, Matsumoto, Mitsuyuki

    “…Background: Fragile X syndrome (FXS) is a genetic condition that causes a range of developmental problems, including intellectual disability, aggressive…”
    Get full text
    Journal Article
  6. 6

    Effects of by Yamazaki, Mayako, Honda, Sokichi, Tamaki, Keisuke, Irie, Megumi, Mihara, Takuma

    Published in PloS one (24-07-2020)
    “…Auditory steady-state responses (ASSRs) are states in which the electrical activity of the brain reacts steadily to repeated auditory stimuli. They are known…”
    Get full text
    Journal Article
  7. 7

    ASP2905, a specific inhibitor of the potassium channel Kv12.2 encoded by the Kcnh3 gene, is psychoactive in mice by Takahashi, Shinji, Okamura, Ai, Yamazaki, Mayako, Ni, Keni

    Published in Behavioural brain research (27-01-2020)
    “…Schizophrenia is a major psychiatric disorder associated with positive and negative symptoms and cognitive impairments. In this study, we used animal models of…”
    Get full text
    Journal Article
  8. 8

    Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3 by Takahashi, Shinji, Inamura, Kohei, Yarimizu, Junko, Yamazaki, Mayako, Murai, Nobuhito, Ni, Keni

    Published in European journal of pharmacology (05-09-2017)
    “…KCNH3 (BEC1) is a member of the ether-à-go-go (KCNH) family of voltage-gated K+ channels. The aim of this study was to determine the pharmacological profiles…”
    Get full text
    Journal Article
  9. 9

    Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability by Chino, Ayaka, Masuda, Naoyuki, Amano, Yasushi, Honbou, Kazuya, Mihara, Takuma, Yamazaki, Mayako, Tomishima, Masaki

    Published in Bioorganic & medicinal chemistry (01-07-2014)
    “…In this study, we report the identification of potent benzimidazoles as PDE10A inhibitors. We first identified imidazopyridine 1 as a high-throughput screening…”
    Get full text
    Journal Article
  10. 10

    ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia by Yamazaki, Mayako, Harada, Katsuya, Yamamoto, Noriyuki, Yarimizu, Junko, Okabe, Mayuko, Shimada, Takeshi, Ni, Keni, Matsuoka, Nobuya

    Published in European neuropsychopharmacology (01-10-2014)
    “…Abstract We recently identified ASP5736, ( N -(diaminomethylene)-1-(3,5-difluoropyridin-4-yl)-4-fluoroisoquinoline-7-carboxamide (2 E )-but-2-enedioate), a…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Fragment-Based Discovery of Pyrimido[1,2-b]indazole PDE10A Inhibitors by Ayaka Chino, Ryushi Seo, Yasushi Amano, Ichiji Namatame, Wataru Hamaguchi, Kazuya Honbou, Takuma Mihara, Mayako Yamazaki, Masaki Tomishima, Naoyuki Masuda

    Published in Chemical and Pharmaceutical Bulletin (01-03-2018)
    “…In this study, we report the identification of potent pyrimidoindazoles as phosphodiesterase10A (PDE10A) inhibitors by using the method of fragment-based drug…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effects of non-steroidal anti-inflammatory drugs on Aβ deposition in Aβ1–42 transgenic C. elegans by Morita, Masahiko, Osoda, Kazuhiko, Yamazaki, Mayako, Shirai, Fumiyuki, Matsuoka, Nobuya, Arakawa, Hiroyuki, Nishimura, Shintaro

    Published in Brain research (12-10-2009)
    “…Abstract Although epidemiological studies have shown that long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs) may protect against…”
    Get full text
    Journal Article
  17. 17

    Effects of non-steroidal anti-inflammatory drugs on Ab deposition in Ab1-42 transgenic C. elegans by Morita, Masahiko, Osoda, Kazuhiko, Yamazaki, Mayako, Shirai, Fumiyuki, Matsuoka, Nobuya, Arakawa, Hiroyuki, Nishimura, Shintaro

    Published in Brain research (12-10-2009)
    “…Although epidemiological studies have shown that long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs) may protect against Alzheimer's…”
    Get full text
    Journal Article
  18. 18

    Effects of non-steroidal anti-inflammatory drugs on Aβ deposition in Aβ 1–42 transgenic C. elegans by Morita, Masahiko, Osoda, Kazuhiko, Yamazaki, Mayako, Shirai, Fumiyuki, Matsuoka, Nobuya, Arakawa, Hiroyuki, Nishimura, Shintaro

    Published in Brain research (2009)
    “…Although epidemiological studies have shown that long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs) may protect against Alzheimer's…”
    Get full text
    Journal Article
  19. 19

    Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats by Tokita, Kenichi, Yamazaki, Shunji, Yamazaki, Mayako, Matsuoka, Nobuya, Mutoh, Seitaro

    Published in Pharmacology, biochemistry and behavior (01-10-2002)
    “…FK960 [ N-(4-acetyl-1-piperazinyl)- p-fluorobenzamide monohydrate] is a novel antidementia drug which has been demonstrated to have potential…”
    Get full text
    Journal Article
  20. 20

    The Possible Role of Age-Related Increase in the Plasma Glucagon/Insulin Ratio in the Enhanced Hepatic Gluconeogenesis and Hyperglycemia in Genetically Diabetic (C57BL/KsJ-db/db) Mice by Kodama, Hiroshi, Fujita, Masataka, Yamazaki, Mayako, Yamaguchi, Isamu

    Published in Japanese Journal of Pharmacology (1994)
    “…Genetically diabetic db/db mice and their normoglycemic littermates (+/+ mice) were studied to determine plasma levels of glucose, glucagon and insulin and…”
    Get full text
    Journal Article